These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 22247488)
1. Increased IL-7 expression in Vogt-Koyanagi-Harada disease. Yang Y; Xiao X; Li F; Du L; Kijlstra A; Yang P Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):1012-7. PubMed ID: 22247488 [TBL] [Abstract][Full Text] [Related]
2. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887 [TBL] [Abstract][Full Text] [Related]
3. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089 [TBL] [Abstract][Full Text] [Related]
4. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease. Chu M; Yang P; Hu R; Hou S; Li F; Chen Y; Kijlstra A Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7084-9. PubMed ID: 21810982 [TBL] [Abstract][Full Text] [Related]
5. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion. Liu L; Yang P; He H; Lin X; Jiang L; Chi W; Zhao C; Zhou H Br J Ophthalmol; 2008 Apr; 92(4):557-61. PubMed ID: 18245271 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease. Li F; Yang P; Liu X; Wang C; Hou S; Kijlstra A Arch Ophthalmol; 2010 Nov; 128(11):1449-54. PubMed ID: 21060047 [TBL] [Abstract][Full Text] [Related]
7. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease. Sun M; Yang P; Du L; Yang Y; Ye J PLoS One; 2014; 9(4):e93214. PubMed ID: 24690905 [TBL] [Abstract][Full Text] [Related]
8. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome. Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome. Xu M; Wang C; Tian Y; Kijlstra A; Yang P Ocul Immunol Inflamm; 2014 Aug; 22(4):294-9. PubMed ID: 24329541 [TBL] [Abstract][Full Text] [Related]
10. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease. Peng Z; Jiang S; Wu M; Zhou X; Wang Q Mol Vis; 2017; 23():538-547. PubMed ID: 28761327 [TBL] [Abstract][Full Text] [Related]
11. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Wang C; Tian Y; Lei B; Xiao X; Ye Z; Li F; Kijlstra A; Yang P Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4668-75. PubMed ID: 22669715 [TBL] [Abstract][Full Text] [Related]
12. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Sugita S; Takase H; Taguchi C; Imai Y; Kamoi K; Kawaguchi T; Sugamoto Y; Futagami Y; Itoh K; Mochizuki M Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of rapamycin and dexamethasone on production of IL-17 and IFN-gamma in Vogt-Koyanagi-Harada patients. Yang K; Wen J; Liu X; Kijlstra A; Chen L; Chi W; Zhou H; Huang X; Yang P Br J Ophthalmol; 2009 Feb; 93(2):249-53. PubMed ID: 19019941 [TBL] [Abstract][Full Text] [Related]
14. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease. Yi X; Yang P; Sun M; Yang Y; Li F Mol Vis; 2011 Mar; 17():673-9. PubMed ID: 21403851 [TBL] [Abstract][Full Text] [Related]
15. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease. Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361 [TBL] [Abstract][Full Text] [Related]
16. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237 [TBL] [Abstract][Full Text] [Related]
17. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease]. Liu YX; Wang H; Peng XY; Zhou ZC Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Liu X; Yang P; Lin X; Ren X; Zhou H; Huang X; Chi W; Kijlstra A; Chen L Clin Immunol; 2009 May; 131(2):333-42. PubMed ID: 19200788 [TBL] [Abstract][Full Text] [Related]
19. Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease. Jiang S; Liu X; Luo L; Qu B; Huang X; Xu L; Lin Y; Ye S; Liu Y Br J Ophthalmol; 2010 Aug; 94(8):1078-82. PubMed ID: 19910285 [TBL] [Abstract][Full Text] [Related]
20. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment. Ye Z; Wang C; Tang J; Zhou Y; Bai L; Liu Y; Kijlstra A; Yang P J Interferon Cytokine Res; 2015 Apr; 35(4):265-72. PubMed ID: 25343528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]